Wang Yuguang is the CEO of Maxinovel Pharmaceuticals, a semi-virtual biotech company he founded in March 2016. Based in Beijing, China.
Wang Yuguang is the CEO of Maxinovel Pharmaceuticals, a semi-virtual biotech company he founded in March 2016. Maxinovel Pharmaceuticals aims to develop a pipeline of orally-active one-pill combinations of immuno-oncology (IO) therapy, targeted therapy, and chemotherapy to treat cancer. The company has global operations with a preclinical lab in Shanghai, a biomarker lab in Guangzhou, clinical operations in Sydney, and a US base in New Jersey. Prior to founding Maxinovel, Wang Yuguang accumulated three decades of industry experience across Big Pharma, biotech, and CRO organizations in China and the US, including working at Schering-Plough and Shanghai ChemPartner.
Full founder directory · Investor directory · Company funding database · Fundraising library